Effect of paricalcitol on endothelial function and inflammation in type 2 diabetes and chronic kidney disease
Authors:
- 1 April 2015
- journal article
- research article
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 29 (3) , 433-437
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protectionClinical Interventions in Aging, 2013
- Vitamin D receptor activation and cardiovascular diseaseNephrology Dialysis Transplantation, 2012
- The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery diseaseVascular Medicine, 2012
- Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathyAmerican Journal of Physiology-Renal Physiology, 2012
- New Insights About Vitamin D and Cardiovascular DiseaseAnnals of Internal Medicine, 2011
- 25-Hydroxyvitamin D and Risk of Myocardial Infarction in MenA Prospective StudyArchives of internal medicine (1960), 2008
- Association between 25-hydroxyvitamin D deficiency and cardiovascular disease in type 2 diabetic patients with mild kidney dysfunctionNephrology Dialysis Transplantation, 2007
- The role of vitamin D in left ventricular hypertrophy and cardiac functionKidney International, 2005
- Vitamin D AnalogsTreatments in Endocrinology, 2002
- Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial arteryJACC, 2002